STADA Arzneimittel AG:企業の戦略・SWOT・財務情報

◆英語タイトル:STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4458
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

STADA Arzneimittel AG – Strategy, SWOT and Corporate Finance Report
Summary

STADA Arzneimittel AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

STADA Arzneimittel (STADA or “the group”) is an international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market. The group operates in Europe and Asia Pacific. STADA is headquartered in Bad Vilbel, Germany.

Scope

- Detailed information on STADA Arzneimittel AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis
- An in-depth view of the business model of STADA Arzneimittel AG including a breakdown and examination of key business segments
- Intelligence on STADA Arzneimittel AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about STADA Arzneimittel AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of STADA Arzneimittel AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess STADA Arzneimittel AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on STADA Arzneimittel AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
STADA Arzneimittel AG: Company Overview 8
STADA Arzneimittel AG: Overview and Key Facts 8
STADA Arzneimittel AG: Overview 8
STADA Arzneimittel AG: Key Facts 8
STADA Arzneimittel AG: Key Employees 9
STADA Arzneimittel AG: Key Employee Biographies 10
STADA Arzneimittel AG: Major Products and Services 11
STADA Arzneimittel AG: Company History 12
STADA Arzneimittel AG: Management Statement 16
STADA Arzneimittel AG: Locations and Subsidiaries 18
STADA Arzneimittel AG: Key Competitors 19
STADA Arzneimittel AG: Company Analysis 20
STADA Arzneimittel AG: Business Description 20
STADA Arzneimittel AG: SWOT Analysis 21
STADA Arzneimittel AG: SWOT Overview 21
STADA Arzneimittel AG: Strengths 21
STADA Arzneimittel AG: Weaknesses 21
STADA Arzneimittel AG: Opportunities 22
STADA Arzneimittel AG: Threats 22
STADA Arzneimittel AG: Corporate Financial Deals Activity 24
STADA Arzneimittel AG: Financial Deals Overview 24
STADA Arzneimittel AG: Targets and Partners 26
STADA Arzneimittel AG: Top Deals 2014 – 2018YTD* 27
STADA Arzneimittel AG: Advisors 28
STADA Arzneimittel AG: Top Financial Advisors 28
STADA Arzneimittel AG: Mergers and Acquisitions 29
STADA Arzneimittel AG: Partnership 30
STADA Arzneimittel AG: Divestments 31
STADA Arzneimittel AG: Private Equity and Ownership 32
STADA Arzneimittel AG: Recent Developments 33
STADA Arzneimittel AG: News and Events Summary 33
STADA Arzneimittel AG: Business Expansion 36
STADA Arzneimittel AG: Contracts 36
STADA Arzneimittel AG: Corporate Governance 37
STADA Arzneimittel AG: Financial Performance 39
STADA Arzneimittel AG: Strategy and Operations 39
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: STADA Arzneimittel AG: Key Facts
Table 2: STADA Arzneimittel AG: Key Employees
Table 3: STADA Arzneimittel AG: Locations and Subsidiaries
Table 4: STADA Arzneimittel AG: Key Competitors
Table 5: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: STADA Arzneimittel AG: M&A Average Deal Size - Value (US$m)
Table 8: STADA Arzneimittel AG: Targets and Partners
Table 9: STADA Arzneimittel AG: Top Deals 2014 - 2018YTD*
Table 10: STADA Arzneimittel AG: Financial Advisor Ranking by Value (US$m)
Table 11: STADA Arzneimittel AG: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: STADA Arzneimittel AG: M&A Activity by Geography (2014 - YTD*2018)
Table 13: STADA Arzneimittel AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: STADA Arzneimittel AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: STADA Arzneimittel AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: STADA Arzneimittel AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 17: STADA Arzneimittel AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 18: STADA Arzneimittel AG: News and Events Summary
Table 19: STADA Arzneimittel AG: Business Expansion
Table 20: STADA Arzneimittel AG: Contracts
Table 21: STADA Arzneimittel AG: Corporate Governance
Table 22: STADA Arzneimittel AG: Financial Performance
Table 23: STADA Arzneimittel AG: Strategy and Operations

List of Figures
Figure 1: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: STADA Arzneimittel AG: M&A Average Deal Size - Value (US$m)
Figure 4: STADA Arzneimittel AG: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: STADA Arzneimittel AG: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: STADA Arzneimittel AG: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: STADA Arzneimittel AG: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: STADA Arzneimittel AG: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: STADA Arzneimittel AG: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 10: STADA Arzneimittel AG: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[STADA Arzneimittel AG:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swiss AviationSoftware Ltd:企業の戦略的SWOT分析
    Swiss AviationSoftware Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ActiveCare Inc:医療機器:M&Aディール及び事業提携情報
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Handok Inc (002390)-製薬・医療分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Cleco Corporate Holdings, LLC:戦略・SWOT・企業財務分析
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • YRC Worldwide Inc.:企業の戦略・SWOT・財務情報
    YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report Summary YRC Worldwide Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Center Parcs (Holdings 1) Limited:企業の戦略・SWOT・財務情報
    Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report Summary Center Parcs (Holdings 1) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • US Physical Therapy Inc (USPH):製薬・医療:M&Aディール及び事業提携情報
    Summary US Physical Therapy Inc (USPh) operates outpatient physical and occupational therapy clinics that offer pre-and post-operative care. The company provides treatment for orthopedic-related disorders, preventative care, sports-related injuries, rehabilitation of injured workers and neurological …
  • Cynosure Inc (CYNO):企業の財務・戦略的SWOT分析
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • ILF Consulting Engineers:企業の戦略・SWOT・財務情報
    ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report Summary ILF Consulting Engineers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Virginia Electric and Power Company:発電所・企業SWOT分析
    Virginia Electric and Power Company – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Exonate Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Exonate Ltd (Exonate) is a biopharmaceutical company that discovers and develops small molecule drugs, which modulates the alternative mRNA splicing for the treatment of unmet medical needs. The company’s alternative mRNA splicing is modulated in disease states that results in the pathologic …
  • Syneron Medical Ltd:企業の戦略的SWOT分析
    Syneron Medical Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Menssana Research Inc:企業の製品パイプライン分析2018
    Summary Menssana Research Inc (Menssana) is a medical device development company that develops breath test systems. The company offers BreathLink a cloud application that concentrates, collects, and analyzes organic compounds in human breath. It also provides Breathscanner a mobile point of care sys …
  • Reece Ltd (REH):企業の財務・戦略的SWOT分析
    Reece Ltd (REH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Athera Biotechnologies AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Athera Biotechnologies AB (Athera) is a clinical stage biopharmaceutical company that focuses on the development of anti-inflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The company develops a proprietary clinical development stage program, …
  • Vattenfall:企業の戦略・SWOT・財務情報
    Vattenfall - Strategy, SWOT and Corporate Finance Report Summary Vattenfall - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆